Telix Pharmaceuticals 1H25 NPAT up 860% to $49.9m, FY25 revenue guidance of $1.18-1.23bn vs. $1.02bn consensus, R&D ...
17h
Hosted on MSNEvening Wrap: ASX 200 tumbles as ANZ, CBA, NAB, and WBC continue to tumble, Telstra shines on buy-backThe S&P/ASX 200 closed 96.4 points lower, down 1.15%. Strong gains in Telstra (TLS) (5.6%) and Whitehaven Coal (WHC) (+8.9%) ...
The S&P/ASX 200 Financials Index has fallen 6.5% over six consecutive sessions, weighed down by poor earnings updates from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results